Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10597 | 1050 | 30.4 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
584 | 3 | POMPE DISEASE//PIN1//CYCLOPHILIN | 15652 |
1662 | 2 | POMPE DISEASE//GLYCOGEN STORAGE DISEASE//GLYCOGEN STORAGE DISEASE TYPE II | 6857 |
10597 | 1 | POMPE DISEASE//GLYCOGEN STORAGE DISEASE TYPE II//ACID ALPHA GLUCOSIDASE | 1050 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | POMPE DISEASE | authKW | 8628772 | 31% | 90% | 330 |
2 | GLYCOGEN STORAGE DISEASE TYPE II | authKW | 3120318 | 11% | 95% | 113 |
3 | ACID ALPHA GLUCOSIDASE | authKW | 2414378 | 9% | 86% | 96 |
4 | ACID MALTASE DEFICIENCY | authKW | 1990497 | 7% | 93% | 74 |
5 | ACID MALTASE | authKW | 890558 | 3% | 88% | 35 |
6 | METAB DIS GENET | address | 774389 | 3% | 76% | 35 |
7 | LYSOSOMAL METAB DIS | address | 654557 | 4% | 49% | 46 |
8 | LATE ONSET POMPE DISEASE | authKW | 615324 | 2% | 92% | 23 |
9 | POMPE | authKW | 549391 | 2% | 82% | 23 |
10 | GLYCOGENOSIS TYPE II | authKW | 499891 | 2% | 90% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Genetics & Heredity | 6327 | 33% | 0% | 343 |
2 | Medicine, Research & Experimental | 3385 | 22% | 0% | 229 |
3 | Clinical Neurology | 2673 | 23% | 0% | 240 |
4 | Endocrinology & Metabolism | 1011 | 13% | 0% | 136 |
5 | Pediatrics | 468 | 8% | 0% | 86 |
6 | Neurosciences | 442 | 14% | 0% | 149 |
7 | Biochemistry & Molecular Biology | 156 | 15% | 0% | 153 |
8 | Medical Laboratory Technology | 143 | 2% | 0% | 23 |
9 | Biotechnology & Applied Microbiology | 119 | 6% | 0% | 63 |
10 | Pathology | 91 | 3% | 0% | 35 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | METAB DIS GENET | 774389 | 3% | 76% | 35 |
2 | LYSOSOMAL METAB DIS | 654557 | 4% | 49% | 46 |
3 | LIGHT IMAGING SECT | 125653 | 1% | 39% | 11 |
4 | GENET DIS GENOM SCI | 116315 | 1% | 67% | 6 |
5 | PEDIAT LYSOSOMAL METAB DIS | 87239 | 0% | 100% | 3 |
6 | POWELL GENE THER Y | 70533 | 3% | 9% | 28 |
7 | CARDIOVASC SCI NEUROL | 65428 | 0% | 75% | 3 |
8 | CHINESE FDN | 58159 | 0% | 100% | 2 |
9 | FONDS ERASME RECH MED | 58159 | 0% | 100% | 2 |
10 | METAB DIS GENET LYSOSOMAL METAB DIS | 58159 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR GENETICS AND METABOLISM | 58146 | 8% | 3% | 79 |
2 | NEUROMUSCULAR DISORDERS | 24991 | 4% | 2% | 45 |
3 | JOURNAL OF INHERITED METABOLIC DISEASE | 15378 | 5% | 1% | 49 |
4 | ORPHANET JOURNAL OF RARE DISEASES | 7538 | 2% | 2% | 17 |
5 | GENETICS IN MEDICINE | 6483 | 2% | 1% | 19 |
6 | MOLECULAR THERAPY | 5942 | 3% | 1% | 27 |
7 | MUSCLE & NERVE | 5888 | 4% | 1% | 38 |
8 | AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS | 4859 | 1% | 2% | 9 |
9 | MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 3985 | 0% | 3% | 5 |
10 | CRC CRITICAL REVIEWS IN CLINICAL NEUROBIOLOGY | 1614 | 0% | 6% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | POMPE DISEASE | 8628772 | 31% | 90% | 330 | Search POMPE+DISEASE | Search POMPE+DISEASE |
2 | GLYCOGEN STORAGE DISEASE TYPE II | 3120318 | 11% | 95% | 113 | Search GLYCOGEN+STORAGE+DISEASE+TYPE+II | Search GLYCOGEN+STORAGE+DISEASE+TYPE+II |
3 | ACID ALPHA GLUCOSIDASE | 2414378 | 9% | 86% | 96 | Search ACID+ALPHA+GLUCOSIDASE | Search ACID+ALPHA+GLUCOSIDASE |
4 | ACID MALTASE DEFICIENCY | 1990497 | 7% | 93% | 74 | Search ACID+MALTASE+DEFICIENCY | Search ACID+MALTASE+DEFICIENCY |
5 | ACID MALTASE | 890558 | 3% | 88% | 35 | Search ACID+MALTASE | Search ACID+MALTASE |
6 | LATE ONSET POMPE DISEASE | 615324 | 2% | 92% | 23 | Search LATE+ONSET+POMPE+DISEASE | Search LATE+ONSET+POMPE+DISEASE |
7 | POMPE | 549391 | 2% | 82% | 23 | Search POMPE | Search POMPE |
8 | GLYCOGENOSIS TYPE II | 499891 | 2% | 90% | 19 | Search GLYCOGENOSIS+TYPE+II | Search GLYCOGENOSIS+TYPE+II |
9 | ENZYME REPLACEMENT THERAPY | 491678 | 12% | 14% | 124 | Search ENZYME+REPLACEMENT+THERAPY | Search ENZYME+REPLACEMENT+THERAPY |
10 | ALGLUCOSIDASE ALFA | 466889 | 2% | 94% | 17 | Search ALGLUCOSIDASE+ALFA | Search ALGLUCOSIDASE+ALFA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VAN DER PLOEG, AT , REUSER, AJJ , (2008) LYSOSOMAL STORAGE DISEASE 2 - POMPE'S DISEASE.LANCET. VOL. 372. ISSUE 9646. P. 1342-1353 | 92 | 81% | 171 |
2 | KISHNANI, PS , BECKEMEYER, AA , (2014) NEW THERAPEUTIC APPROACHES FOR POMPE DISEASE: ENZYME REPLACEMENT THERAPY AND BEYOND.PEDIATRIC ENDOCRINOLOGY REVIEWS PER. VOL. 12. ISSUE . P. 114 -124 | 83 | 94% | 9 |
3 | TARNOPOLSKY, M , KATZBERG, H , PETROF, BJ , SIRRS, S , SARNAT, HB , MYERS, K , DUPRE, N , DODIG, D , GENGE, A , VENANCE, SL , ET AL (2016) POMPE DISEASE: DIAGNOSIS AND MANAGEMENT. EVIDENCE-BASED GUIDELINES FROM A CANADIAN EXPERT PANEL.CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. VOL. 43. ISSUE 4. P. 472 -485 | 98 | 75% | 0 |
4 | SCHULLER, A , WENNINGER, S , STRIGL-PILL, N , SCHOSER, B , (2012) TOWARD DECONSTRUCTING THE PHENOTYPE OF LATE-ONSET POMPE DISEASE.AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS. VOL. 160C. ISSUE 1. P. 80 -88 | 67 | 94% | 28 |
5 | KROOS, M , HOOGEVEEN-WESTERVELD, M , VAN DER PLOEG, A , REUSER, AJJ , (2012) THE GENOTYPE-PHENOTYPE CORRELATION IN POMPE DISEASE.AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS. VOL. 160C. ISSUE 1. P. 59-68 | 62 | 98% | 31 |
6 | AL JASMI, F , AL JUMAH, M , ALQARNI, F , AL-SANNA'A, N , AL-SHARIF, F , BOHLEGA, S , CUPLER, EJ , FATHALLA, W , HAMDAN, MA , MAKHSEED, N , ET AL (2015) DIAGNOSIS AND TREATMENT OF LATE-ONSET POMPE DISEASE IN THE MIDDLE EAST AND NORTH AFRICA REGION: CONSENSUS RECOMMENDATIONS FROM AN EXPERT GROUP.BMC NEUROLOGY. VOL. 15. ISSUE . P. - | 70 | 91% | 0 |
7 | BEMBI, B , CERINI, E , DANESINO, C , DONATI, MA , GASPERINI, S , MORANDI, L , MUSUMECI, O , PARENTI, G , RAVAGLIA, S , SEIDITA, F , ET AL (2008) MANAGEMENT AND TREATMENT OF GLYCOGENOSIS TYPE II.NEUROLOGY. VOL. 71. ISSUE 23. P. S12-S36 | 85 | 75% | 25 |
8 | TURACA, LT , DE FARIA, DOS , KYOSEN, SO , TEIXEIRA, VD , MOTTA, FL , PESSOA, JG , SILVA, MRE , ALMEIDA, SS , D'ALMEIDA, V , ROJAS, MVM , ET AL (2015) NOVEL GAA MUTATIONS IN PATIENTS WITH POMPE DISEASE.GENE. VOL. 561. ISSUE 1. P. 124 -131 | 60 | 92% | 0 |
9 | RICHARD, E , DOUILLARD-GUILLOUX, G , CAILLAUD, C , (2011) NEW INSIGHTS INTO THERAPEUTIC OPTIONS FOR POMPE DISEASE.IUBMB LIFE. VOL. 63. ISSUE 11. P. 979 -986 | 62 | 95% | 7 |
10 | CHIEN, YH , HWU, WL , LEE, NC , (2013) POMPE DISEASE: EARLY DIAGNOSIS AND EARLY TREATMENT MAKE A DIFFERENCE.PEDIATRICS AND NEONATOLOGY. VOL. 54. ISSUE 4. P. 219-227 | 60 | 87% | 16 |
Classes with closest relation at Level 1 |